CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
暂无分享,去创建一个
F. Bova | J. Yang | Jianping Huang | Zhiguo Lin | A. Grippin | D. Rajon | Qiong J. Wang | D. Mitchell | Maryam Rahman | Meng Na | Yu Long | L. Deleyrolle | E. Sayour | J. Kresak | A. Karachi | Linchun Jin | K. Dyson | Haipeng Tao | Wang Zhang | Alicia Y Hou